English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/131010
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Engineered nanoparticles for improved vasoactive intestinal peptide (VIP) biomedical applications

AuthorsKlippstein, Rebecca ; Pozo, David
KeywordsNeuropeptide
Surface funcionalization
Immunomodulation
Cancer
VIP receptors
VIP
Issue Date2011
PublisherBentham Science Publishers
CitationRecent Patents on Nanomedicine 1(1): 55-59 (2011)
AbstractNanotechnology can address key bottlenecks hindering successful bench to bedside translation of recent research in the development of neuropeptide-based drugs. This is the case for vasoactive intestinal peptide (VIP), where sustained interest in its therapeutic applications needs to devise new methodologies to improve its drugability or to convey innovation to diagnostics to identify cells that result from conditions such as carcinoid metastasis in which VPAC receptors are involved. We analyze here current technologies and patent disclosing methods on surface functionalization or encapsulation to obtain VIP engineered nanoparticles.
URIhttp://hdl.handle.net/10261/131010
Identifiersissn: 1877-9123
e-issn: 1877-9131
Appears in Collections:(CABIMER) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.